Sit Investment Associates Inc. Acquires 11,050 Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Sit Investment Associates Inc. grew its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 104.7% in the fourth quarter, HoldingsChannel.com reports. The fund owned 21,600 shares of the company’s stock after purchasing an additional 11,050 shares during the period. Sit Investment Associates Inc.’s holdings in Establishment Labs were worth $995,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. R Squared Ltd bought a new stake in Establishment Labs during the fourth quarter valued at approximately $36,000. KLP Kapitalforvaltning AS purchased a new stake in shares of Establishment Labs during the 4th quarter valued at $161,000. Handelsbanken Fonder AB lifted its holdings in shares of Establishment Labs by 32.3% during the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company’s stock worth $378,000 after acquiring an additional 2,000 shares during the last quarter. Verition Fund Management LLC grew its position in Establishment Labs by 22.8% in the third quarter. Verition Fund Management LLC now owns 9,400 shares of the company’s stock worth $407,000 after acquiring an additional 1,746 shares in the last quarter. Finally, HighTower Advisors LLC increased its stake in Establishment Labs by 32.5% in the third quarter. HighTower Advisors LLC now owns 10,311 shares of the company’s stock valued at $446,000 after acquiring an additional 2,529 shares during the last quarter. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Establishment Labs Stock Performance

Establishment Labs stock opened at $32.30 on Monday. The firm has a fifty day simple moving average of $36.67 and a two-hundred day simple moving average of $40.61. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. Establishment Labs Holdings Inc. has a twelve month low of $28.16 and a twelve month high of $60.12. The company has a market capitalization of $931.73 million, a PE ratio of -12.52 and a beta of 0.77.

Establishment Labs (NASDAQ:ESTA) last issued its earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.64) by ($0.34). Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The firm had revenue of $44.51 million during the quarter, compared to the consensus estimate of $44.45 million. Research analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Stephens reaffirmed an “overweight” rating and set a $52.00 price target on shares of Establishment Labs in a research note on Thursday, March 6th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, Establishment Labs presently has an average rating of “Moderate Buy” and a consensus target price of $57.40.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.